litlas
ログインアカウント作成

Stephen Gottschalk

1988–2026 年に発表

141
論文数
18,722
被引用数
78
h 指数
134
i10 指数

被引用数

Stephen Gottschalk の年別被引用数1988 年: 被引用 2 件1989 年: 被引用 13 件1990 年: 被引用 14 件1991 年: 被引用 11 件1992 年: 被引用 6 件1993 年: 被引用 9 件1994 年: 被引用 8 件1995 年: 被引用 5 件1996 年: 被引用 11 件1997 年: 被引用 10 件1998 年: 被引用 18 件1999 年: 被引用 19 件2000 年: 被引用 13 件2001 年: 被引用 6 件2002 年: 被引用 16 件2003 年: 被引用 20 件2004 年: 被引用 32 件2005 年: 被引用 19 件2006 年: 被引用 22 件2007 年: 被引用 28 件2008 年: 被引用 36 件2009 年: 被引用 47 件2010 年: 被引用 59 件2011 年: 被引用 56 件2012 年: 被引用 52 件2013 年: 被引用 121 件2014 年: 被引用 84 件2015 年: 被引用 129 件2016 年: 被引用 152 件2017 年: 被引用 216 件2018 年: 被引用 300 件2019 年: 被引用 750 件2020 年: 被引用 978 件2021 年: 被引用 1,054 件2022 年: 被引用 1,085 件2023 年: 被引用 989 件2024 年: 被引用 1,397 件2025 年: 被引用 889 件2026 年: 被引用 23 件

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 2,621 件、この内訳の 32%中国: 引用元論文 1,301 件、この内訳の 15.9%ドイツ: 引用元論文 517 件、この内訳の 6.3%イギリス: 引用元論文 390 件、この内訳の 4.8%イタリア: 引用元論文 331 件、この内訳の 4.1%フランス: 引用元論文 267 件、この内訳の 3.3%オーストラリア: 引用元論文 197 件、この内訳の 2.4%カナダ: 引用元論文 197 件、この内訳の 2.4%スペイン: 引用元論文 173 件、この内訳の 2.1%スイス: 引用元論文 172 件、この内訳の 2.1%オランダ: 引用元論文 165 件、この内訳の 2%日本: 引用元論文 159 件、この内訳の 1.9%
0%32%その他 20.7%

機関

分野

  • Medicine74.4%
  • Biochemistry, Genetics and Molecular Biology13.7%
  • Immunology and Microbiology9.6%
  • Engineering0.9%
  • Materials Science0.5%
  • Neuroscience0.4%
  • その他0.5%

トピック

  • CAR-T cell therapy research19.9%
  • Immune Cell Function and Interaction7.6%
  • Virus-based gene therapy research7.4%
  • Immunotherapy and Immune Responses6%
  • Nanowire Synthesis and Applications4.1%
  • Cancer Immunotherapy and Biomarkers4%
  • その他51%

共著者

全論文

検索で開く
  1. HER2-Specific Chimeric Antigen Receptor–Modified Virus-Specific T Cells for Progressive Glioblastoma

    著者: Nabil Ahmed, Vita S. Brawley, Meenakshi Hegde, Kevin Bielamowicz, Mamta Kalra, Daniel Landi, Catherine Robertson, Tara Gray, Oumar Diouf, Amanda Wakefield, Alexia Ghazi, Claudia Gerken, Zhongzhen Yi, Aidin Ashoori, Meng-Fen Wu, Hao Liu, Cliona M. Rooney, Gianpietro Dotti, Adrian P. Gee, Jack Su, Yvonne Kew, David S. Baskin, Yi Jonathan Zhang, Pamela New, Bambi Grilley, Milica Stojakovic, John Hicks, Suzanne Z. Powell, Malcolm K. Brenner, Helen E. Heslop, Robert G. Grossman, Winfried S. Wels, Stephen Gottschalk - JAMA Oncology 2017 被引用: 837

  2. Deleting DNMT3A in CAR T cells prevents exhaustion and enhances antitumor activity

    著者: Brooke Prinzing, Caitlin C. Zebley, Christopher T. Petersen, Yiping Fan, Alejandro Allo Anido, Zhongzhen Yi, Phuong Nguyen, Haley Houke, Matthew Bell, Dalia Haydar, Charmaine Brown, Shannon K. Boi, Shanta Alli, Jeremy Chase Crawford, Janice M. Riberdy, Jeoung-Eun Park, Sheng Zhou, Mireya Paulina Velasquez, Chris DeRenzo, Cícera R. Lazzarotto, Shengdar Q. Tsai, Peter Vogel, Shondra M. Pruett‐Miller, Deanna Langfitt, Stephen Gottschalk, Ben Youngblood, Giedre Krenciute - Science Translational Medicine 2021 被引用: 332

  3. Human Epidermal Growth Factor Receptor 2 (HER2) –Specific Chimeric Antigen Receptor–Modified T Cells for the Immunotherapy of HER2-Positive Sarcoma

    著者: Nabil Ahmed, Vita S. Brawley, Meenakshi Hegde, Catherine Robertson, Alexia Ghazi, Claudia Gerken, Enli Liu, Olga Dakhova, Aidin Ashoori, Amanda Corder, Tara Gray, Meng-Fen Wu, Hao Liu, John Hicks, Nino Rainusso, Gianpietro Dotti, Zhuyong Mei, Bambi Grilley, Adrian P. Gee, Cliona M. Rooney, Malcolm K. Brenner, Helen E. Heslop, Winfried S. Wels, Lisa L. Wang, Peter M. Anderson, Stephen Gottschalk - Journal of Clinical Oncology 2015 被引用: 979

  4. Tandem CAR T cells targeting HER2 and IL13Rα2 mitigate tumor antigen escape

    著者: Meenakshi Hegde, Malini Mukherjee, Zakaria Grada, Antonella Pignata, Daniel Landi, Shoba A. Navai, Amanda Wakefield, Kristen Fousek, Kevin Bielamowicz, Kevin Chow, Vita S. Brawley, Tiara T. Byrd, Simone Krebs, Stephen Gottschalk, Winfried S. Wels, Matthew L. Baker, Gianpietro Dotti, Maksim Mamonkin, Malcolm K. Brenner, Jordan S. Orange, Nabil Ahmed - Journal of Clinical Investigation 2016 被引用: 672

  5. RASA2 ablation in T cells boosts antigen sensitivity and long-term function

    著者: Julia Carnevale, Eric Shifrut, Nupura Kale, William A. Nyberg, Franziska Blaeschke, Yan Yi Chen, Zhongmei Li, Sagar P. Bapat, Morgan E. Diolaiti, Patrick C. O’Leary, Shane Vedova, Julia A. Belk, Bence Dániel, Theodore L. Roth, Stefanie Bachl, Alejandro Allo Anido, Brooke Prinzing, Jorge Ibañez-Vega, Shannon Lange, Dalia Haydar, Marie Luetke-Eversloh, Maëlys Born-Bony, Bindu Hegde, Scott C. Kogan, Tobias Feuchtinger, Hideho Okada, Ansuman T. Satpathy, Kevin Shannon, Stephen Gottschalk, Justin Eyquem, Giedre Krenciute, Alan Ashworth, Alexander Marson - Nature 2022 被引用: 223

  6. CAR T Cell Therapy for Solid Tumors: Bright Future or Dark Reality?

    著者: Jessica Wagner, Elizabeth Wickman, Christopher DeRenzo, Stephen Gottschalk - Molecular Therapy 2020 被引用: 374

  7. CD70-specific CAR T cells have potent activity against acute myeloid leukemia without HSC toxicity

    著者: Tim Sauer, Kathan Parikh, Sandhya Sharma, Bilal Omer, David Sedloev, Qian Chen, Linus Angenendt, Christoph Schliemann, Michael Schmitt, Carsten Müller‐Tidow, Stephen Gottschalk, Cliona M. Rooney - Blood 2021 被引用: 217

  8. Interleukin-15-armoured GPC3 CAR T cells for patients with solid cancers

    著者: Pavel Sumazin, Andras Heczey, John M. Maris, Antonino Montalbano, Amy N. Courtney, Jennifer Pogoriler, Sachin G. Thakkar, Gianpietro Dotti, David Steffin, Premal Lulla, Natalia Lapteva, Dolores López‐Terrada, Zhuyong Mei, Carlos A. Ramos, Malcolm K. Brenner, Ramy Sweidan, Stephen Gottschalk, Huimin Zhang, Nisha Ghatwai, Navin Varadarajan, Leonid S. Metelitsa, Kalyani Patel, Helen E. Heslop, Azlann Arnett, Prakash Masand, Tao Wang, Tannaz Armaghany, Julien Fleurence, Purva Rathi, Bambi Grilley, Daniel Martínez, Deborah Lyon - Nature 2024 被引用: 207

  9. Engineered Cytokine Signaling to Improve CAR T Cell Effector Function

    著者: Matthew Bell, Stephen Gottschalk - Frontiers in Immunology 2021 被引用: 151

  10. Transgenic Expression of IL15 Improves Antiglioma Activity of IL13Rα2-CAR T Cells but Results in Antigen Loss Variants

    著者: Giedre Krenciute, Brooke Prinzing, Zhongzhen Yi, Meng-Fen Wu, Hao Liu, Gianpietro Dotti, Irina V. Balyasnikova, Stephen Gottschalk - Cancer Immunology Research 2017 被引用: 312

  11. Antitumor Effects of Chimeric Receptor Engineered Human T Cells Directed to Tumor Stroma

    著者: Sunitha Kakarla, Kevin Chow, Melinda Mata, Donald R. Shaffer, Xiao‐Tong Song, Meng-Fen Wu, Hao Liu, Lisa L. Wang, David R. Rowley, Klaus Pfizenmaier, Stephen Gottschalk - Molecular Therapy 2013 被引用: 338

  12. Constitutive Signaling from an Engineered IL7 Receptor Promotes Durable Tumor Elimination by Tumor-Redirected T Cells

    著者: Thomas Shum, Bilal Omer, Haruko Tashiro, Robert L. Kruse, Dimitrios L. Wagner, Kathan Parikh, Zhongzhen Yi, Tim Sauer, Daofeng Liu, Robin Parihar, Paul Castillo, Hao Liu, Malcolm K. Brenner, Leonid S. Metelitsa, Stephen Gottschalk, Cliona M. Rooney - Cancer Discovery 2017 被引用: 292

  13. Off-the-Shelf Virus-Specific T Cells to Treat BK Virus, Human Herpesvirus 6, Cytomegalovirus, Epstein-Barr Virus, and Adenovirus Infections After Allogeneic Hematopoietic Stem-Cell Transplantation

    著者: Ifigeneia Tzannou, Αναστασία Παπαδοπούλου, Swati Naik, Kathryn Leung, Caridad Martinez, Carlos A. Ramos, George Carrum, Ghadir Sasa, Premal Lulla, Ayumi Watanabe, Manik Kuvalekar, Adrian P. Gee, Meng-Fen Wu, Hao Liu, Bambi Grilley, Robert A. Krance, Stephen Gottschalk, Malcolm K. Brenner, Cliona M. Rooney, Helen E. Heslop, Ann M. Leen, Bilal Omer - Journal of Clinical Oncology 2017 被引用: 450

  14. Allogeneic CAR Cell Therapy—More Than a Pipe Dream

    著者: Kenneth J. Caldwell, Stephen Gottschalk, Aimee C. Talleur - Frontiers in Immunology 2021 被引用: 128

  15. NK Cells Expressing a Chimeric Activating Receptor Eliminate MDSCs and Rescue Impaired CAR-T Cell Activity against Solid Tumors

    著者: Robin Parihar, Charlotte Helena Rivas, Mai Huynh, Bilal Omer, Natalia Lapteva, Leonid S. Metelitsa, Stephen Gottschalk, Cliona M. Rooney - Cancer Immunology Research 2019 被引用: 249

  16. Cell-surface antigen profiling of pediatric brain tumors: B7-H3 is consistently expressed and can be targeted via local or systemic CAR T-cell delivery

    著者: Dalia Haydar, Haley Houke, Jason Chiang, Zhongzhen Yi, Zelda Odé, Kenneth J. Caldwell, Xiaoyan Zhu, Kimberly Mercer, Jennifer L. Stripay, Timothy I. Shaw, Peter Vogel, Christopher DeRenzo, Suzanne J. Baker, Martine F. Roussel, Stephen Gottschalk, Giedre Krenciute - Neuro-Oncology 2020 被引用: 144

  17. Design and development of therapies using chimeric antigen receptor‐expressing T cells

    著者: Gianpietro Dotti, Stephen Gottschalk, Barbara Savoldo, Malcolm K. Brenner - Immunological Reviews 2013 被引用: 507

  18. Tumor response and endogenous immune reactivity after administration of HER2 CAR T cells in a child with metastatic rhabdomyosarcoma

    著者: Meenakshi Hegde, Sujith K. Joseph, Farzana Pashankar, Christopher DeRenzo, Khaled Sanber, Shoba A. Navai, Tiara T. Byrd, John Hicks, Mina L. Xu, Claudia Gerken, Mamta Kalra, Catherine Robertson, Huimin Zhang, Ankita Shree, Birju Mehta, Olga Dakhova, Vita S. Salsman, Bambi Grilley, Adrian P. Gee, Gianpietro Dotti, Helen E. Heslop, Malcolm K. Brenner, Winfried S. Wels, Stephen Gottschalk, Nabil Ahmed - Nature Communications 2020 被引用: 167

  19. CD19-CAR T cells undergo exhaustion DNA methylation programming in patients with acute lymphoblastic leukemia

    著者: Caitlin C. Zebley, Charmaine Brown, Mi Tian, Yiping Fan, Shanta Alli, Shannon K. Boi, Giovanni Galletti, Enrico Lugli, Deanna Langfitt, Jean‐Yves Métais, Timothy Lockey, Michael M. Meagher, Brandon M. Triplett, Aimee C. Talleur, Stephen Gottschalk, Ben Youngblood - Cell Reports 2021 被引用: 103

  20. IL15 modification enables CAR T cells to act as a dual targeting agent against tumor cells and myeloid-derived suppressor cells in GBM

    著者: Μαρκέλλα Ζαννίκου, Joseph Duffy, Rebecca Levine, Maggie Seblani, Qianli Liu, Aaron Presser, Víctor A. Arrieta, Christopher J. Chen, Adam M. Sonabend, Craig Horbinski, Catalina Lee-Chang, Jason Miska, Maciej S. Lesniak, Stephen Gottschalk, Irina V. Balyasnikova - Journal for ImmunoTherapy of Cancer 2023 被引用: 82

  21. Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial

    著者: Meenakshi Hegde, Shoba A. Navai, Christopher DeRenzo, Sujith K. Joseph, Khaled Sanber, Meng‐Fen Wu, Ahmed Z. Gad, Katherine A. Janeway, Matthew Campbell, Dolores Mullikin, Zeid Nawas, Catherine Robertson, Pretty Mathew, Huimin Zhang, Birju Mehta, Raksha R. Bhat, Angela M. Major, Ankita Shree, Claudia Gerken, Mamta Kalra, Rikhia Chakraborty, Sachin G. Thakkar, Olga Dakhova, Vita S. Salsman, Bambi Grilley, Natalia Lapteva, Adrian P. Gee, Gianpietro Dotti, Riyue Bao, Ahmed Hamed Salem, Tao Wang, Malcolm K. Brenner, Helen E. Heslop, Winfried S. Wels, John Hicks, Stephen Gottschalk, Nabil Ahmed - Nature Cancer 2024 被引用: 80

  22. Synapse-tuned CARs enhance immune cell anti-tumor activity

    著者: Peter Chockley, Jorge Ibañez-Vega, Giedre Krenciute, Lindsay J. Talbot, Stephen Gottschalk - Nature Biotechnology 2023 被引用: 57

  23. T cell dysfunction and therapeutic intervention in cancer

    著者: Caitlin C. Zebley, Dietmar Zehn, Stephen Gottschalk, Hongbo Chi - Nature Immunology 2024 被引用: 115

  24. HER2-Specific T Cells Target Primary Glioblastoma Stem Cells and Induce Regression of Autologous Experimental Tumors

    著者: Nabil Ahmed, Vita S. Salsman, Yvonne Kew, Donald R. Shaffer, Suzanne Z. Powell, Yi J Zhang, Robert G. Grossman, Helen E. Heslop, Stephen Gottschalk - Clinical Cancer Research 2010 被引用: 386